ESC Premium Access

ST-2 as a predictor of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair

Congress Presentation

About the speaker

Professor Oliver Doerr

University hospital Giessen and Marburg, Giessen (Germany)
0 follower

26 more presentations in this session

Clinical profile and prognosis of acute heart failure complicating severe aortic stenosis: Insights from the CURRENT AS Registry

Speaker: Doctor K. Nagao (Kyoto, JP)

Thumbnail

Effects of dabigatran on prothrombin, factor VII and tissue factor expression in human aortic valve interstitial cells

Speaker: Doctor E. Wypasek (Cracow, PL)

Thumbnail

30 days and one year impact of the antithrombotic treatment following TAVI

Speaker: Doctor P. Balagny (Paris, FR)

Thumbnail

Clinical impact of permanent pacemaker after aortic valve implantation with corevalve prosthesis: long term follow-up.

Speaker: Doctor J. Lopez Aguilera (Cordoba, ES)

Thumbnail

Prevalence and main correlates of right ventricular dysfunction in patients with severe aortic stenosis and preserved left ventricular ejection fraction

Speaker: Doctor A. Mateescu (Bucharest, RO)

Thumbnail

Access the full session

Poster session 5 - Valvular disease

Speakers: Professor O. Doerr, Doctor K. Nagao, Doctor E. Wypasek, Doctor P. Balagny, Doctor J. Lopez Aguilera...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb